ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 29 filers reported holding ACER THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $42,000 | – | 1,365 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 158,787 | $544,000 | 0.27% |
| Nantahala Capital Management | 990,655 | $3,398,000 | 0.10% |
| FEDERATED HERMES, INC. | 146,097 | $501,000 | 0.00% |
| Paloma Partners Management Co | 24,100 | $83,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 16,984 | $58,000 | 0.00% |
| Berman Capital Advisors, LLC | 1,093 | $3,000 | 0.00% |
| JANE STREET GROUP, LLC | 18,574 | $64,000 | 0.00% |
| NORTHERN TRUST CORP | 30,269 | $103,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 11 | $0 | 0.00% |